MS
Mark Sullivan
Chief Legal Officer

Mark Sullivan insider trades: Definium Therapeutics (DFTX) stock sales

Chief Legal Officer, Definium Therapeutics Last trade Sep 25, 2026 25 Form 4 filings
$514K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2011
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mark reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 25, 2026DFTX↓ Sell$514K
Sep 25, 2025MNMD↓ Sell$110K
Jun 25, 2025MNMD↓ Sell$78K
Mar 25, 2025MNMD↓ Sell10b5-1$44K
Dec 26, 2024MNMD↓ Sell$34K
Sep 25, 2024MNMD↓ Sell$26K
Jun 25, 2024MNMD↓ Sell10b5-1$129K
Mar 2, 2023SESN↓ Sell$129K
Feb 21, 2023SESN↓ Sell$23K
Dec 14, 2011MEDH↓ Sell$44K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other DFTX insiders

Open-market trades in the last 12 months

About Mark Sullivan's insider trades

Mark Sullivan is Chief Legal Officer at Definium Therapeutics (DFTX). Since Dec 14, 2011, Mark has reported no open-market purchases and 10 sales worth $1.1M on SEC Form 4. In the last 12 months: 1 sale ($514K).

2 sales (15% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (13 filings), shares withheld for taxes (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DFTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.